Bloomberg
Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as soon as this quarter.
View original source — Bloomberg ↗
Related stories
ABC News
BusinessJul 17, 2026 · 1 min
Why oil prices are about to surge
ABC News
CNBC
BusinessJul 17, 2026 · 1 min
Iraq and Syria sign agreement to restore oil pipeline that would provide alternative to Strait of Hormuz
CNBC
Financial Times
BusinessJul 17, 2026 · 1 min
Meta and Anthropic in talks for up to $10bn data centre deal
Financial Times
Bloomberg
BusinessJul 17, 2026 · 1 min
US Oil Rig Count Notches Longest Streak Without Drop Since 2022
Bloomberg